StellarOne Corp’s Exelixis EXEL Stock Holding History

StellarOne Corp’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$0	Hold	7	–	–	﹤0.01%	230
2013 Q2	$0	Buy	+7	New	+$33	﹤0.01%	231

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

StellarOne Corp's EXEL Position: Q3 2013 in Review

StellarOne Corp held its Exelixis (EXEL) position steady in Q3 2013 at 7 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #230.

StellarOne Corp first reported a position in EXEL in Q2 2013 and has held it in 2 quarters since. 126 funds tracked by Wall St. Rank hold EXEL as of Q3 2013.

StellarOne Corp held 7 shares of Exelixis worth $0 as of Q3 2013.
StellarOne Corp left its Exelixis share count unchanged in Q3 2013.
Exelixis made up ﹤0.01% of StellarOne Corp's portfolio in Q3 2013, its #230 holding.
StellarOne Corp first reported a position in Exelixis in Q2 2013 and has held it in 2 quarters since.
126 funds tracked by Wall St. Rank held Exelixis as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.